Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 8Multiple Myeloma 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Inflammation 2Frailty 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Ventilator-Induced Lung Injury 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Postoperative Complications 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mucositis 1

Interventions

Gemcitabine 5Nivolumab 3Irinotecan 3Ipilimumab 3Docetaxel 3Cyclophosphamide 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3pegfilgrastim 2Vincristine 2Temozolomide 2Ibandronic Acid 2Everolimus 2Doxorubicin 2CTLA-4 Antigen 2spartalizumab 1saracatinib 1samarium Sm-153 lexidronam 1pembrolizumab 1palbociclib 1liposomal doxorubicin 1lenvatinib 1fludarabine 1anlotinib 1angiotensin I (1-7) 1aldesleukin 1Zoledronic Acid 1Trabectedin 1Topotecan 1Taxes 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Bone Neoplasms × Ascorbic Acid × Clear all
NCT03468075 2020-12-10

Gemcitabine Plus Ascorbate for Sarcoma in Adults

University of Iowa

Phase 2 Terminated
10 enrolled 13 charts
Sarcoma

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡